Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for liver disease

T J Davern1, B F Scharschmidt

  • 1Department of Medicine, University of California, San Francisco 94143-0538, USA.

Digestive Diseases (Basel, Switzerland)
|April 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate.

Molecular genetics and metabolism reports·2017
Same author

Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary.

Metabolic brain disease·2016
Same author

Refeeding syndrome in a young woman with argininosuccinate lyase deficiency.

Molecular genetics and metabolism reports·2016
Same author

Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy.

Digestive diseases and sciences·2016
Same author

Glutamine and hyperammonemic crises in patients with urea cycle disorders.

Molecular genetics and metabolism·2015
Same author

Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.

Molecular genetics and metabolism·2013

Gene therapy offers potential for treating diseases by delivering therapeutic genes. This review examines gene delivery systems for liver disease, highlighting challenges for clinical application.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Genetics

Background:

  • Recent biomedical advances have enabled gene-level disease treatment.
  • Gene therapy development focuses on effective gene delivery into cells.
  • The liver serves as a key model organ for gene transfer technologies.

Purpose of the Study:

  • To review current gene delivery systems for liver disease.
  • To identify attributes and limitations of existing gene therapy approaches.
  • To highlight obstacles hindering clinical application of hepatic gene therapy.

Main Methods:

  • Literature review of gene delivery systems.
  • Analysis of gene transfer techniques in liver disease models.
  • Evaluation of challenges in hepatic gene therapy.

Related Experiment Videos

Main Results:

  • Various gene delivery systems have been explored for liver applications.
  • Current systems possess specific advantages and disadvantages.
  • Significant hurdles remain for successful clinical translation.

Conclusions:

  • Hepatic gene therapy holds promise but requires further development.
  • Overcoming current limitations is crucial for clinical success.
  • Continued research into gene delivery is essential for advancing liver disease treatment.